檢索結果 - Aliyu Tijjani
- Showing 1 - 3 results of 3
-
1
Moderate fixed‐dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the <scp>SPIN</scp> trial 由 Najibah A. Galadanci, Shehu U. Abdullahi, Shehi Ali Abubakar, Binta W. Jibir, Hauwa Aminu, Aliyu Tijjani, Muhammad Aliyu Abba, Musa A. Tabari, Aisha A. Galadanci, Awwal Musa Borodo, Raymond Belonwu, Auwal Salihu, Mark Rodeghier, Djamila L. Ghafuri, Brittany V. Covert Greene, Kathleen Neville, Adetola A. Kassim, Fenella J. Kirkham, Lori C. Jordan, Muktar H. Aliyu, Michael R. DeBaun
出版 2020Carta -
2
Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial 由 Shehu U. Abdullahi, Binta W. Jibir, Halima Bello‐Manga, Safiya Gambo, Hauwa Inuwa, Aliyu Tijjani, Nura Idris, Aisha A. Galadanci, Mustapha S. Hikima, Najibah A. Galadanci, Awwal Musa Borodo, Abdulkadir Musa Tabari, Lawal Haliru, Aisha Suleiman, Jamila Ibrahim, Brittany Covert Greene, Djamila L. Ghafuri, Mark Rodeghier, James C. Slaughter, Fenella J. Kirkham, Kathleen Neville, Adetola A. Kassim, Edwin Trevathan, Lori C. Jordan, Muktar H. Aliyu, Michael R. DeBaun
出版 2021Artigo -
3
Primary Prevention of Stroke in Children with Sickle Cell Disease in Sub-Saharan Africa: Rationale and Design of Phase III Randomized Clinical Trial 由 Abdullahi, Shehu U., Wudil, Binta J., Bello-Manga, Halima, Musa, Aisha B., Gambo, Safiya, Galadanci, Najibah A., Aminu, Hauwa, Gaya, Aliyu Tijjani, Sanusi, Surayya, Tabari, Musa A., Galadanci, Aisha, Borodo, Awwal, Abba, Muhammed S., Dambatta, Abdu H., Haliru, Lawal, Gambo, Awwal, Cassell, Holly, Rodeghier, Mark, Ghafuri, Djamila L., Greene, Brittany V. Covert, Neville, Kathleen, Kassim, Adetola A., Kirkham, Fenella, Trevathan, Edwin, Jordan, Lori C., Aliyu, Muktar H., DeBaun, Michael R.
出版 2020Text
相關主題
Engineering
Internal medicine
Mechanical engineering
Medicine
Pediatrics
Stroke (engine)
Transcranial Doppler
Adverse effect
Anemia
Blood transfusion
Clinical endpoint
Clinical trial
Disease
Environmental health
Incidence (geometry)
Optics
Physical therapy
Physics
Population
Randomized controlled trial
Sickle cell anemia
Transfusion therapy